Assessing the evidence on remdesivir

Lancet Infect Dis. 2021 Dec;21(12):1630-1631. doi: 10.1016/S1473-3099(21)00695-2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives*
  • Adenosine Monophosphate / therapeutic use
  • Alanine / analogs & derivatives*
  • Alanine / therapeutic use
  • Antiviral Agents / therapeutic use*
  • COVID-19 / drug therapy
  • Humans
  • Randomized Controlled Trials as Topic
  • SARS-CoV-2
  • Treatment Outcome

Substances

  • Antiviral Agents
  • remdesivir
  • Adenosine Monophosphate
  • Alanine

Supplementary concepts

  • COVID-19 drug treatment